Evolution in the Treatment of Esophageal Disease at a Single Academic Institution: 2004-2013

J Laparoendosc Adv Surg Tech A. 2017 Sep;27(9):915-923. doi: 10.1089/lap.2017.0069. Epub 2017 May 9.

Abstract

Introduction: Management of benign and malignant esophageal disease has changed rapidly over the past decade. The aim of this study was to analyze evolution in surgical management of esophageal disease at a single academic medical center during this period.

Materials and methods: We reviewed a retrospective cohort of patients who underwent esophagectomy between 2004 and 2013. Patient, institutional, treatment, and outcomes variables were reviewed.

Results: 317 patients were analyzed. Median age was 63.5 years; 80% were male. Average inhospital mortality rate was 3.8%. Operative indications changed significantly from 2004 to 2013, with more operations performed for invasive malignancy (77% vs. 95%) and fewer for high-grade dysplasia (12% vs. 3%, P = .008). In 2004, Ivor Lewis esophagectomy was the most common surgical technique, but the three-field technique was the operation of choice in 2013. A minimally invasive approach was used in 19% of cases in 2004 and 100% of cases in 2013 (P < .001). Anastomotic leak ranged from 0% to 21% with no significant difference over the study period (P = .18). Median lymph node harvest increased from seven to 18 nodes from 2004 to 2013 (P = .001). Hospital length of stay decreased from 15 to 8 days (P = .001). In 2013, 79% of patients were discharged to home, compared to 73% in 2004 (P = .04).

Discussion: Over the last decade, our treatment of esophageal disease has evolved from a predominantly open Ivor Lewis to a minimally invasive three-field approach. Operations for malignancy have also increased dramatically. Postoperative complications and mortality were not significantly changed, but were consistently low during the latter years of the study.

Keywords: cancer outcomes; esophageal cancer; esophagectomy; esophagectomy-minimally invasive surgery.

MeSH terms

  • Adult
  • Aged
  • Anastomosis, Surgical / methods
  • Anastomotic Leak / surgery
  • Antineoplastic Agents / therapeutic use*
  • Chemoradiotherapy / methods*
  • Esophageal Diseases
  • Esophageal Neoplasms / therapy*
  • Esophagectomy / methods*
  • Female
  • Hospital Mortality
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures / methods
  • Neoadjuvant Therapy
  • Postoperative Complications / surgery
  • Retrospective Studies

Substances

  • Antineoplastic Agents